BRD4 inhibitor MZ1 exerts anti-cancer effects by targeting MYCN and MAPK signaling in neuroblastoma.
Zhang X, Guo X, Zhuo R, Tao Y, Liang W, Yang R, Chen Y, Cao H, Jia S, Yu J, Liao X, Li X, Fang F, Li G, Wu D, Xu Y, Li Z, Pan J, Wang J.
Zhang X, et al. Among authors: zhuo r.
Biochem Biophys Res Commun. 2022 May 14;604:63-69. doi: 10.1016/j.bbrc.2022.03.039. Epub 2022 Mar 9.
Biochem Biophys Res Commun. 2022.
PMID: 35299072